Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 146.40
Day range
SAR 142.60 - SAR 147.20
Year range
SAR 90.20 - SAR 197.60
Market cap
2.90B SAR
Avg Volume
278.54K
P/E ratio
44.12
Dividend yield
-
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 94.96M | 11.87% |
Operating expense | 33.36M | 12.69% |
Net income | 24.14M | 15.57% |
Net profit margin | 25.42 | 3.29% |
Earnings per share | — | — |
EBITDA | 29.09M | 19.59% |
Effective tax rate | 5.13% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.11M | -36.50% |
Total assets | 444.90M | 0.55% |
Total liabilities | 138.50M | -14.60% |
Total equity | 306.40M | — |
Shares outstanding | 20.00M | — |
Price to book | 9.56 | — |
Return on assets | 15.25% | — |
Return on capital | 18.53% | — |
Cash Flow
Net change in cash
| (SAR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 24.14M | 15.57% |
Cash from operations | 31.21M | 3.01% |
Cash from investing | -9.97M | -49.70% |
Cash from financing | -18.61M | -5.19% |
Net change in cash | 2.62M | -55.83% |
Free cash flow | 8.84M | -9.15% |
About
Founded
1998
Headquarters
Website
Employees
543
